Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.

Drew DA, Chin SM, Gilpin KK, Parziale M, Pond E, Schuck MM, Stewart K, Flagg M, Rawlings CA, Backman V, Carolan PJ, Chung DC, Colizzo FP 3rd, Freedman M, Gala M, Garber JJ, Huttenhower C, Kedrin D, Khalili H, Kwon DS, Markowitz SD, Milne GL, Nishioka NS, Richter JM, Roy HK, Staller K, Wang M, Chan AT.

Trials. 2017 Feb 1;18(1):50. doi: 10.1186/s13063-016-1744-z.

2.

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.

Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG; APC Trial Collaborators, Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Ratain MJ, Nakamura Y, Weiss ST, Tomlinson I, Bertagnolli MM.

Clin Cancer Res. 2013 Dec 1;19(23):6430-7. doi: 10.1158/1078-0432.CCR-13-0550. Epub 2013 Oct 1.

3.

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG; Adenoma Prevention with Celecoxib (APC) Study Investigators.

Cancer Prev Res (Phila). 2010 May;3(5):588-96. doi: 10.1158/1940-6207.CAPR-09-0271. Epub 2010 Apr 19.

4.

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET; Adenoma Prevention with Celecoxib Study Investigators.

Cancer Prev Res (Phila). 2009 Apr;2(4):310-21. doi: 10.1158/1940-6207.CAPR-08-0206. Epub 2009 Mar 31.

5.

Dual antagonists of platelet activating factor and histamine. 3. Synthesis, biological activity and conformational implications of substituted N-acyl-bis-arylcycloheptapiperazines.

Piwinski JJ, Wong JK, Green MJ, Kaminski JJ, Colizzo F, Albanese MM, Ganguly AK, Billah MM, Anthes JC, West RE Jr.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3469-74.

PMID:
9934454
6.

Correlation of high-frequency esophageal ultrasonography and manometry in the study of esophageal motility.

Miller LS, Liu JB, Colizzo FP, Ter H, Marzano J, Barbarevech C, Helwig K, Leung L, Goldberg BB, Hedwig K [corrected to Helwig K].

Gastroenterology. 1995 Sep;109(3):832-7. Erratum in: Gastroenterology 1996 Feb;110(2):655.

PMID:
7657111
7.

Ciliated respiratory epithelial surface changes after formaldehyde exposure.

Colizzo F, Krantz MJ, Fish JE, Hastie AT.

J Toxicol Environ Health. 1992 Apr;35(4):221-34.

PMID:
1533681
8.

Initial characterization of tektins in cilia of respiratory epithelial cells.

Hastie A, Colizzo F, Evans L, Krantz M, Fish J.

Chest. 1992 Mar;101(3 Suppl):47S-48S. No abstract available.

PMID:
1541203
9.

Identification of surface components of mammalian respiratory tract cilia.

Hastie AT, Krantz MJ, Colizzo FP.

Cell Motil Cytoskeleton. 1990;17(4):317-28.

PMID:
2076548

Supplemental Content

Loading ...
Support Center